trending Market Intelligence /marketintelligence/en/news-insights/trending/71xbZVxVuuwa49JXeAw1xA2 content esgSubNav
In This List

RJ Biotech fiscal Q1 profit climbs YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021


RJ Biotech fiscal Q1 profit climbs YOY

RJ Biotech Ltd. said its normalized net income for the fiscal first quarter ended June 30 came to 1.64 Indian rupees per share, a gain of 32.7% from 1.23 rupees per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 15.5 million rupees, a gain from 4.4 million rupees in the year-earlier period.

The normalized profit margin increased to 8.8% from 4.4% in the year-earlier period.

Total revenue climbed 75.8% year over year to 176.1 million rupees from 100.2 million rupees, and total operating expenses grew 63.4% year over year to 142.7 million rupees from 87.4 million rupees.

Reported net income rose year over year to 24.8 million rupees, or 2.62 rupees per share, from 7.0 million rupees, or 1.98 rupees per share.

As of Aug. 11, US$1 was equivalent to 61.19 Indian rupees.